Dali Pharmaceuticalco.,Ltd (603963.SS)
CNY 2.96
(-3.27%)
CNY 2.96
(-3.27%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 87.26 Million | 132.34 Million | 171.49 Million | 213.58 Million | 294.32 Million | 401.48 Million |
| Cost of Revenue | 50.97 Million | 57.78 Million | 45.94 Million | 57.06 Million | 73.21 Million | 79.43 Million |
| Gross Profit | 36.29 Million | 74.55 Million | 125.55 Million | 156.51 Million | 221.1 Million | 322.05 Million |
| Operating Expenses | 56.92 Million | 96.95 Million | 138.78 Million | 158.14 Million | 210.72 Million | 312.08 Million |
| Selling, General and Administrative Expenses | 45 Million | 78.73 Million | 120.59 Million | 137.97 Million | 191.72 Million | 287.37 Million |
| Research and Development Expenses | 839.52 Thousand | 926.98 Thousand | 1.44 Million | 2.82 Million | 2.23 Million | 2.23 Million |
| Other Expenses | 3.59 Million | 17.29 Million | 16.74 Million | 17.34 Million | 16.76 Million | 996.58 Thousand |
| Cost and Expenses | 104.3 Million | 154.74 Million | 184.72 Million | 215.21 Million | 283.93 Million | 391.51 Million |
| Operating Income | -17.03 Million | -22.39 Million | -9.33 Million | -2.36 Million | 15.95 Million | 11.62 Million |
| Interest Expense | 1.72 Million | 1.07 Million | 247.34 Thousand | 32.21 Thousand | 39.59 Thousand | 567.91 Thousand |
| Income Tax Expense | 2.66 Million | 703.96 Thousand | 298.69 Thousand | 544.24 Thousand | 3.61 Million | 1.91 Million |
| Earnings before Tax | -17.36 Million | -16.99 Million | -41.59 Million | 3.77 Million | 17.12 Million | 12.61 Million |
| Net Income | -20.03 Million | -17.7 Million | -41.89 Million | 3.23 Million | 13.5 Million | 10.7 Million |
| Earnings Per Share Basic | -0.09 | -0.08 | -0.19 | 0.01 | 0.06 | 0.05 |
| Earnings Per Share Diluted | -0.09 | -0.08 | -0.19 | 0.01 | 0.06 | 0.05 |
| Weighted Average Shares Outstanding | 222.57 Million | 219.7 Million | 219.7 Million | 219.7 Million | 219.7 Million | 231.61 Million |
| Weighted Average Shares Outstanding (Diluted) | 222.57 Million | 219.7 Million | 219.7 Million | 219.7 Million | 219.7 Million | 231.84 Million |
| Gross Margin | 0.42 | 0.56 | 0.73 | 0.73 | 0.75 | 0.80 |
| EBIT Margin | 0.00 | -0.03 | 0.05 | 0.06 | 0.12 | 0.09 |
| Profit Margin | -0.23 | -0.13 | -0.24 | 0.02 | 0.05 | 0.03 |
| EBITDA | 360.83 Thousand | -11.7 Million | -23.78 Million | 14.3 Million | 22.51 Million | 31.33 Million |
| Earnings Before Tax Margin | -0.20 | -0.17 | -0.05 | -0.01 | 0.05 | 0.03 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 19.37 Million | 11.44 Million | 14.7 Million | 13.99 Million | 87.26 Million | 13.7 Million |
| Cost of Revenue | 19.46 Million | 11.94 Million | 13.53 Million | 13.01 Million | 50.97 Million | 8.77 Million |
| Gross Profit | -91.94 Thousand | -500.52 Thousand | 1.17 Million | 982.34 Thousand | 36.29 Million | 4.93 Million |
| Operating Expenses | 7.35 Million | 6.53 Million | 7.61 Million | 8.94 Million | 60.42 Million | 10.46 Million |
| Selling, General and Administrative Expenses | 7.19 Million | 6.36 Million | 6.91 Million | -3.57 Million | - | 15.61 Million |
| Research and Development Expenses | 96.67 Thousand | 67.8 Thousand | 699.46 Thousand | 176.96 Thousand | - | 78.97 Thousand |
| Other Expenses | -65.11 Thousand | -98.26 Thousand | 35.17 Thousand | 1930.77 | -332.95 Thousand | 5368.58 |
| Cost and Expenses | 26.81 Million | 18.47 Million | 21.14 Million | 21.95 Million | 111.39 Million | 19.23 Million |
| Operating Income | -7.44 Million | -7.03 Million | -6.43 Million | -3.83 Million | -17.03 Million | -4.57 Million |
| Interest Expense | 219.83 Thousand | 249.2 Thousand | 269.29 Thousand | 343.15 Thousand | 1.7 Million | 365.25 Thousand |
| Income Tax Expense | 262.58 Thousand | 595.52 Thousand | -252.28 Thousand | 808.79 Thousand | 2.66 Million | 36.45 Thousand |
| Earnings before Tax | -7.31 Million | -6.18 Million | -5.62 Million | -3.83 Million | -17.36 Million | -4.57 Million |
| Net Income | -7.58 Million | -6.77 Million | -5.37 Million | -4.64 Million | -20.03 Million | -4.6 Million |
| Earnings Per Share Basic | -0.03 | -0.03 | -0.02 | -0.02 | - | -0.02 |
| Earnings Per Share Diluted | -0.03 | -0.03 | -0.02 | -0.02 | - | -0.02 |
| Weighted Average Shares Outstanding | 219.7 Million | 219.7 Million | 219.7 Million | 225.54 Million | 222.57 Million | 219.7 Million |
| Weighted Average Shares Outstanding (Diluted) | 219.7 Million | 219.7 Million | 219.7 Million | 225.54 Million | 222.57 Million | 219.7 Million |
| Gross Margin | -0.00 | -0.04 | 0.08 | 0.07 | 0.42 | 0.36 |
| EBIT Margin | -0.37 | -0.43 | -0.42 | -0.56 | - | -0.39 |
| Profit Margin | -0.39 | -0.59 | -0.37 | -0.33 | -0.23 | -0.34 |
| EBITDA | -7.09 Million | -4.86 Million | -6.19 Million | -7.85 Million | - | -5.4 Million |
| Earnings Before Tax Margin | -0.38 | -0.61 | -0.44 | -0.27 | -0.20 | -0.33 |
SHRICON
ORGN
002019
300486
DNA
EGS745W1C011